US Patent 7371379 Dosages for treatment with anti-ErbB2 antibodies
Patent 7371379 was granted and assigned to Genentech on May, 2008 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7371379 Dosages for treatment with anti-ErbB2 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.